Information Journal Paper
APA:
Copy. (2018). Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. INTERNATIONAL JOURNAL OF NANOMEDICINE, 13(-), 8339-8354. SID. https://sid.ir/paper/678525/en
Vancouver:
Copy. Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. INTERNATIONAL JOURNAL OF NANOMEDICINE[Internet]. 2018;13(-):8339-8354. Available from: https://sid.ir/paper/678525/en
IEEE:
Copy, “Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy,” INTERNATIONAL JOURNAL OF NANOMEDICINE, vol. 13, no. -, pp. 8339–8354, 2018, [Online]. Available: https://sid.ir/paper/678525/en